PrimeRFP SCOUT · Federal Contract Recompete Brief

HHSO100200600013CCLOSE contract and deobligate EXCESS FUNDS — Dynport Vaccine Company LLC

Dynport Vaccine Company LLC holds $-100,967,056 across 18 federal awards. Competition previously drew 8 offers. Set-aside status: NONE. PoP ended Jan 30, 2012 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Barda - Aspr / Daappo / Barda Dcma
Awarding office
Department of Health and Human Services (HHS)
Agency
Dynport Vaccine Company LLC
Recipient
Jan 30, 2012
PoP end
$-7,163,741.07
Obligated
325414
NAICS
6505
PSC
NONE
Set-aside
8 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

NONE
Contract numberHHSO100200600013C
AgencyDepartment of Health and Human Services (HHS)
Awarding officeBarda - Aspr / Daappo / Barda Dcma
IncumbentDynport Vaccine Company LLC
UEILXNEGTYDR755
NAICS325414

No full NAICS 325414 intel page yet. Browse NAICS intelligence

PSC6505
Place of performanceFREDERICK, MD
PoP end (current)Jan 30, 2012
Obligated$-7,163,741.07

CLOSE CONTRACT AND DEOBLIGATE EXCESS FUNDS is a federal NONE award for Department of Health and Human Services (HHS) held by Dynport Vaccine Company LLC. Estimated value $235.1M ($-7,163,741.07 obligated). Current period of performance ends Jan 30, 2012. Last award drew 8 bidders. Place of performance: FREDERICK, MD.

CLOSE CONTRACT AND DEOBLIGATE EXCESS FUNDS

Recompete timing

Public
● Past PoP end (5367 days ago)

Current PoP ended Jan 30, 2012 (5367 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Want the durability read on HHSO100200600013C? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Dynport Vaccine Company LLC — $-100,967,056 obligated across 18 awards (firm-wide, all agencies).

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract HHSO100200600013C?

HHSO100200600013C (CLOSE contract and deobligate EXCESS FUNDS) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $235.1M, currently held by Dynport Vaccine Company LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded HHSO100200600013C?

Barda - Aspr / Daappo / Barda Dcma awarded HHSO100200600013C to Dynport Vaccine Company LLC.

Who is the incumbent on HHSO100200600013C?

Dynport Vaccine Company LLC is the incumbent with $-100,967,056 across 18 related awards in SCOUT’s public footprint. The current period of performance ends Jan 30, 2012.

When does Dynport Vaccine Company LLC’s HHSO100200600013C come up for recompete?

SCOUT tracks a period-of-performance end of Jan 30, 2012. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on HHSO100200600013C? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HHSO100200600013C